Curable compositions and membranes

US9556316B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9556316-B2
Application numberUS-201414897358-A
CountryUS
Kind codeB2
Filing dateMay 30, 2014
Priority dateJun 11, 2013
Publication dateJan 31, 2017
Grant dateJan 31, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A composition comprising: a) 5 to 65 wt % of curable compound comprising one ethylenically unsaturated group and at least one anionic group; b) 2.5 to 70 wt % of crosslinking agent comprising at least two acrylic groups; c) a tertiary amine; and d) 0 to 45 wt % of inert solvent; wherein the molar ratio of component c) to a) is at least 0.7. Also described are a process for making composite membranes and the resultant membranes.

First claim

Opening claim text (preview).

The invention claimed is: 1. A curable composition comprising: a) 5 to 65 wt % of curable compound comprising one ethylenically unsaturated group and at least one anionic group; b) 2.5 to 70 wt % of crosslinking agent comprising at least two acrylic groups; c) a tertiary amine; and d) 0 to 45 wt % of inert solvent; wherein the molar ratio of component c) to a) is at least 0.7. 2. The composition according to claim 1 wherein the molar ratio of component c) to a) is at least 0.9. 3. The composition according to claim 1 wherein the crosslinking agent has a melting point below 80° C., when measured at atmospheric pressure. 4. The composition according to claim 1 wherein the anionic group is selected from sulpho, carboxy and phosphato groups. 5. The composition according to claim 1 wherein the anionic group is a sulpho group. 6. The composition according to claim 1 which comprises at least 5 wt % and less than 70 wt % of the said crosslinking agent. 7. The composition according to claim 1 wherein the said crosslinking agent has a solubility in water of less than 0.03 mol/l, when measured at 25° C. 8. The composition according to claim 1 wherein the weight ratio of component b) to component a) is greater than 0.3. 9. The composition according to claim 1 which further comprises 0.05 to 10 wt % of photoinitiator. 10. The composition according to claim 1 wherein the said crosslinking agent comprises at least two groups selected from acrylamide groups. 11. The composition according to claim 1 wherein the said tertiary amine has a melting point below 50° C. 12. The composition according to claim 1 wherein the said tertiary amine is selected from tri(C 1-12 -alkyl)amines and heterocyclic N—(C 1-12 -alkyl) amines. 13. The composition according to claim 1 wherein the said curable compound has a MW of less than 1000 Dalton and/or said crosslinking agent has a MW of less than 1000 Dalton. 14. The composition according to claim 1 wherein the said tertiary amine has a MW of less than 400 Dalton. 15. The composition according to claim 1 which has a viscosity of below 12 Pa.s when measured at 50° C. 16. A process for preparing a membrane comprising the following steps: a) applying a curable composition to a support; and b) curing the composition to form a membrane; wherein the composition is as defined in claim 1 . 17. The process according to claim 16 wherein the curing is performed by a process comprising irradiating the composition for less than 30 seconds. 18. A cation exchange membrane including a cured composition comprising, prior to curing, a) 5 to 65 wt % of curable compound comprising one ethylenically unsaturated group and at least one anionic group; b) 2.5 to 70 wt % of crosslinking agent comprising at least two acrylic groups; c) a tertiary amine; and d) 0 to 45 wt % of inert solvent; wherein the molar ratio of component c) to a) is at least 0.7. 19. An electrodialysis or reverse electrodialysis unit, a flow through capacitor device, an electrodeionization module, a continuous electrodeionization module, a fuel cell, a diffusion dialysis apparatus, a membrane distillation module or a membrane electrode assembly comprising one or more membranes including a cured composition comprising, prior to curing, a) 5 to 65 wt % of curable compound comprising one ethylenically unsaturated group and at least one anionic group; b) 2.5 to 70 wt % of crosslinking agent comprising at least two acrylic groups; c) a tertiary amine; and d) 0 to 45 wt % of inert solvent; wherein the molar ratio of component c) to a) is at least 0.7. 20. The composition according to claim 1 wherein: (a) the crosslinking agent has (i) a melting point below 80° C., when measured at atmospheric pressure; and (ii) a solubility in water of less than 0.03 mol/l, when measured at 25° C.; (b) the composition comprises at least 5 wt % and less than 70 wt % of the said crosslinking agent; (c) the composition further comprises 0.05 to 10 wt % of photoinitiator; (d) the weight ratio of component b) to component a) is greater than 0.3; and (e) the anionic group is a sulpho group. 21. The composition according to claim 1 wherein: (a) the said tertiary amine has a melting point below 50° C.; (b) the said tertiary amine is selected from tri(C 1-12 -alkyl)amines and heterocyclic N—(C 1-12 -alkyl) amines; and (c) the said curable compound has a MW of less than 1000 Dalton; (d) the said crosslinking agent has a MW of less than 1000 Dalton; and (e) the said tertiary amine has a MW of less than 400 Dalton. 22. The composition according to claim 1 wherein: (a) the crosslinking agent has a melting point below 80° C., when measured at atmospheric pressure; (b) the anionic group is a sulpho group; (c) the composition comprises at least 5 wt % and less than 70 wt % of the said crosslinking agent; (d) the said crosslinking agent has a solubility in water of less than 0.03 mol/l, when measured at 25° C., and has a MW of less than 1000 Dalton; (e) the weight ratio of component b) to component a) is greater than 0.3; and (f) the composition comprises 0.05 to 10 wt % of photoinitiator; (g) the said tertiary amine is selected from tri(C 1-12 -alkyl)amines and heterocyclic N—(C 1-12 -alkyl) amines and has a melting point below 50° C. and a MW of less than 400 Dalton; and (h) the said curable compound has a MW of less than 1000 Dalton. 23. The process according to claim 16 wherein: (a) the composition comprises a crosslinking agent having a melting point below 80° C., when measured at atmospheric pressure; (b) the anionic group is a sulpho group; (c) the composition comprises at least 5 wt % and less than 70 wt % of the said crosslinking agent; (d) the said crosslinking agent has a solubility in water of less than 0.03 mol/l, when measured at 25° C. and has a MW of less than 1000 Dalton; (e) the weight ratio of component b) to component a) is greater than 0.3; (f) the composition comprises 0.05 to 10 wt % of photoinitiator; (g) the said tertiary amine is selected from tri(C 1-12 -alkyl)amines and heterocyclic N—(C 1-12 -alkyl) amines and has a melting point below 50° C. and a MW of less than 400 Dalton; and (h) the said curable compound has a MW of less than 1000 Dalton. 24. A cation exchange membrane including a cured composition comprising, prior to curing, a) 5 to 65 wt % of curable compound comprising one ethylenically unsaturated group and at least one anionic group; b) 2.5 to 70 wt % of crosslinking agent comprising at least two acrylic groups; c) a tertiary amine; and d) 0 to 45 wt % of inert solvent; wherein the molar ratio of component c) to a) is at least 0.7, wherein (e) the composition comprises a crosslinking agent having a melting point below 80° C., when measured at atmospheric pressure; (f) the anionic group is a sulpho group; (g) the composition comprises at least 5 wt % and less than 70 wt % of the said crosslinking agent; (h) the said crosslinking agent has a solubility in water of less than 0.03 mol/l, when measured at 25° C. and has a MW of less than 1000 Dalton; (i) the weight ratio of component b) to component a) is greater than 0.3; (j) the composition comprises 0.05 to 10 wt % of photoinitiator; (k) the said tertiary amine is selected from tri(C 1-12 -alkyl)amines and heterocyclic N—(C 1-12 -alkyl) amines and has a melting point below 50° C. and a MW o

Assignees

Inventors

Classifications

  • and containing other heteroatoms, e.g. 2-acrylamido-2-methylpropane sulfonic acid [AMPS] · CPC title

  • characterised by their properties · CPC title

  • electrodeionisation · CPC title

  • Homopolymers or copolymers of amides or imides · CPC title

  • by membrane distillation (distillation and evaporation without the use of membranes C02F1/04) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9556316B2 cover?
A composition comprising: a) 5 to 65 wt % of curable compound comprising one ethylenically unsaturated group and at least one anionic group; b) 2.5 to 70 wt % of crosslinking agent comprising at least two acrylic groups; c) a tertiary amine; and d) 0 to 45 wt % of inert solvent; wherein the molar ratio of component c) to a) is at least 0.7. Also described are a process for making composite memb…
Who is the assignee on this patent?
Fujifilm Mfg Europe Bv
What technology area does this patent fall under?
Primary CPC classification C08J5/2243. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).